Yesuneh Tefera Mekasha | Pharmaceutical Sciences | Best Researcher Award

Mr. Yesuneh Tefera Mekasha | Pharmaceutical Sciences | Best Researcher Award

Mr. Yesuneh Tefera Mekasha , University of Gondra , Ethiopia

Yesuneh Tefera Mekasha (BVPharm, HDP, MSc) is a researcher and academic in the field of pharmaceutical quality assurance and regulatory affairs. Based at the University of Gondar, Ethiopia, his expertise lies in drug discovery, development, pharmacovigilance, and quality assurance of pharmaceutical products. He has published numerous papers on various aspects of pharmaceutical quality, with a focus on quality control parameters, regulatory affairs, and antimicrobial stewardship. He is passionate about improving the healthcare system in Ethiopia through research and education, working closely with students, collaborators, and the pharmaceutical industry. As a peer reviewer for international journals, he actively contributes to advancing pharmaceutical sciences globally.

Publication Profile:

Orcid

Strengths for the Award:

Yesuneh Tefera Mekasha is a highly accomplished researcher in the field of pharmaceutical quality assurance and regulatory affairs. He holds a Master’s degree in Pharmaceutical Quality Assurance and Regulatory Affairs with a remarkable GPA of 3.91/4. His research is diverse, covering critical areas such as drug discovery, post-market pharmaceutical quality, pharmacovigilance, and antimicrobial stewardship. He has published 15 papers as a corresponding author in reputable journals and contributed significantly to the improvement of pharmaceutical practices, particularly in Ethiopia. His expertise in quality control methods, like High-Performance Liquid Chromatography (HPLC), and his application of dissolution profile modeling, make him a leading figure in pharmaceutical research. Furthermore, his teaching experience and mentorship of students demonstrate his commitment to education and the next generation of pharmaceutical professionals.

Areas for Improvements:

Despite his impressive track record, there are opportunities for Yesuneh to expand his research internationally and enhance his engagement in collaborative projects across various global research institutions. Additionally, increasing interdisciplinary collaboration could further strengthen his contributions to innovative pharmaceutical solutions, particularly in the areas of policy advocacy and regulatory reforms. Broadening the scope of his research to include emerging trends like digital health and precision medicine could also add value to his expertise.

Education:

Yesuneh holds a Bachelor of Veterinary Pharmacy degree, a Higher Diploma Programme Certificate in Teaching Method, and a Master of Science in Pharmaceutical Quality Assurance and Regulatory Affairs from the University of Jimma, Ethiopia, with a GPA of 3.91/4. His MSc thesis focused on evaluating the quality control of Azithromycin tablets marketed in Ethiopia. He also holds certificates in health economics, chemical assessment, and emergency response from organizations such as the World Bank Group, WHO, and Stockholm University.

Experience:

Yesuneh currently serves as an academic research advisor in pharmaceutical quality assurance and regulatory affairs at the University of Gondar. He teaches various undergraduate courses in pharmaceutical sciences and guides students through research. He collaborates with Jimma University’s pharmaceutical quality assurance team to conduct post-market quality evaluations of medicines. His laboratory experience spans pharmaceutical analysis techniques like HPLC, UV spectroscopy, and mass spectrometry. He is an active member of both national and international pharmaceutical societies and has contributed to improving pharmaceutical practices in Ethiopia through his teaching, research, and practical industry work.

Awards and Honors:

Yesuneh was awarded a gold medal by the University of Gondar in 2018 for academic excellence in Veterinary Pharmacy. He also completed a short-term training program in China on social governance and capacity building. His contributions to quality control testing in Ethiopia earned him recognition from an Ethiopian pharmaceutical company. In addition, his work has been acknowledged by his peers, including international accolades for his academic and research achievements, with a notable publication record in prestigious journals.

Research Focus:

Yesuneh’s research focuses on pharmaceutical quality assurance, regulatory affairs, antimicrobial stewardship, and pharmacovigilance. His work investigates quality control in pharmaceutical products, dissolution profile modeling, and the interchangeability of drugs in clinical practice. Additionally, he examines pharmaceutical policies, particularly in Ethiopia and East Africa, addressing challenges related to substandard medicines and regulatory constraints. His research aims to improve public health outcomes through enhanced drug safety, efficacy, and availability, focusing on critical aspects of the pharmaceutical industry in resource-limited settings.

Publications Top Notes:

  1. A narrative review on problems in product quality, regulatory system constraints, and the concept of quality by design as a solution for quality assurance of African medicines. βœοΈπŸ“–
  2. Assessment of the extent and monetary loss in selected public hospitals in Jimma Zone, Ethiopia: expired medicine perspectives. πŸ’°πŸ©Ί
  3. Modeling and comparison of dissolution profiles for different brands of albendazole boluses. πŸ’ŠπŸ”¬
  4. Quality evaluation of selected expired fluoroquinolones medicines obtained from the public hospitals in Jimma zone, Oromia regional state, Ethiopia. πŸ₯πŸ’‰
  5. Substandard and falsified antimicrobials in selected East African countries: A systematic review. πŸŒπŸ’Š
  6. Traditional herbal medicine regulatory implementation in Ethiopia: a qualitative study. πŸŒ±πŸ“œ
  7. Evaluation of the Knowledge, Attitudes, and Practices of Veterinary Professionals Regarding Antimicrobial Use and Resistance in Central Gondar Zone, Ethiopia. πŸΎπŸ’‘
  8. In vitro comparative quality evaluation of different brands of Amlodipine Tablets in Jimma Town, Ethiopia. πŸ’ŠπŸ§ͺ
  9. Evaluating the Knowledge, Practice, and Regulatory Situation of Veterinary Experts Regarding Counterfeit Veterinary Medications in Ethiopia. πŸ„πŸ’Ό
  10. Dissolution profile evaluation of selected brands of amoxicillin-clavulanate potassium tablets in Hawassa town, Sidama Region. πŸ’ŠπŸ§¬

Conclusion:

Yesuneh Tefera Mekasha is undoubtedly a strong candidate for the Research for Best Researcher Award. His contributions to the pharmaceutical field, especially in improving quality assurance systems and addressing the challenges faced by the pharmaceutical industry in Ethiopia, are commendable. His academic excellence, research output, and dedication to public health through improving drug safety and quality are clear indicators of his potential to continue driving impactful change in the pharmaceutical industry. With continued growth and more international collaboration, Yesuneh’s research will undoubtedly contribute to advancing global pharmaceutical standards.

 

 

 

Ihab Ibrahim | Pharmacology | Best Researcher Award

Dr. Ihab Ibrahim | Pharmacology | Best Researcher Award

Dr. Ihab Ibrahim , University Of Baghdad College Of Medicine , Iraq

Ihab Abdulwahid Ibrahim is a clinical pharmacist based at the University of Baghdad, College of Medicine, Iraq. He holds a pivotal role in both teaching and research, contributing significantly to the field of pharmacology, with a special interest in the effects of medications and herbs. With a passion for improving healthcare practices, he integrates knowledge from medical books, research papers, and teaching hospitals to develop practical solutions. He actively critiques and enhances existing research, ensuring it aligns with the latest scientific developments. His dedication to advancing medical research has led to his involvement in the publication of scientific articles and collaboration with peers to foster a deeper understanding of pharmacological impacts on human health. Ihab strives for continuous improvement in his field, with a clear focus on advancing healthcare practices and research in Iraq.

Publication Profile:

Orcid

Strengths for the Award:

Ihab Abdulwahid Ibrahim is a clinical pharmacist with a strong academic background and a deep commitment to advancing research in pharmacology. His research focus on the pharmacological effects of medications and herbs demonstrates his expertise in bridging theoretical knowledge with real-world applications. His contributions include critical analysis of medical literature, which aids in refining existing research. Ihab’s publication in the Tissue and Cell journal is a notable achievement, underscoring his ability to contribute to high-impact scientific discussions. Additionally, his research methods, which integrate insights from medical books, hospital experiences, and detailed critique of research papers, provide practical value to the scientific community. His passion for healthcare and research is evident in his continuous engagement with both academic and clinical environments.

Areas for Improvement:

While Ihab’s work is commendable, there are opportunities for him to expand his research scope by engaging in international collaborations. Increased involvement in multi-institutional studies could enhance the global reach of his research and lead to more significant innovations. Furthermore, publishing more articles in internationally recognized journals indexed in SCI and Scopus would boost his visibility and citation impact. Expanding his research to include emerging areas within pharmacology and pursuing more interdisciplinary projects could also amplify his contributions.

Education:

Ihab Abdulwahid Ibrahim completed his education at the University of Baghdad, where he earned a degree in pharmacy. His academic journey continued with further studies and specialized training in clinical pharmacology. Through his educational endeavors, Ihab acquired in-depth knowledge of pharmacology, medicinal chemistry, and the therapeutic effects of drugs. This strong foundation in pharmacological sciences led to his appointment as a clinical pharmacist at the prestigious University of Baghdad, College of Medicine. He remains committed to lifelong learning, constantly enhancing his expertise by attending workshops, courses, and academic conferences. Through this dedication, he continuously stays updated with the latest advancements in the field of clinical pharmacy and research. His rigorous academic background, combined with his practical experience, allows him to contribute meaningfully to both the academic and healthcare sectors.

Experience:

Ihab Abdulwahid Ibrahim has accumulated valuable professional experience as a clinical pharmacist at the University of Baghdad, College of Medicine, Iraq. In this capacity, he is involved in teaching, research, and the application of clinical pharmacology. Ihab has engaged in detailed research and critical review of the pharmacological effects of medications and herbs, contributing to the development of evidence-based practices. His practical experience working with teaching hospitals has been instrumental in linking theoretical knowledge with real-world clinical applications. In addition to his academic roles, Ihab actively engages in consulting on various pharmaceutical and healthcare projects. His ability to analyze and synthesize research enables him to contribute meaningfully to medical literature, as evidenced by his published work in peer-reviewed journals. Ihab’s broad professional experience, combined with his passion for advancing pharmaceutical research, has made him a respected figure in his field.

Research Focus:

Ihab Abdulwahid Ibrahim’s research focuses on the pharmacological effects of medications and herbs, with an emphasis on improving therapeutic outcomes and patient care. His primary area of interest lies in the scientific investigation of how different drugs and herbal remedies interact with the human body, particularly their effects on various physiological systems. Through meticulous research, he seeks to uncover new insights into the safety, efficacy, and optimal use of medications, contributing to evidence-based practices in clinical pharmacy. Ihab also critically reviews and analyzes research papers, ensuring that his work is informed by the latest advancements in pharmacology. By exploring the therapeutic potential of herbs, his research offers valuable insights into traditional and modern medicine. His work contributes not only to academic knowledge but also to the development of improved clinical practices and patient care in healthcare settings.

Publications Top Notes:

  1. Pharmacological Effects of Medicinal Herbs: A Comprehensive Review 🌿
  2. Innovations in Clinical Pharmacology: New Perspectives in Drug Therapy πŸ’Š
  3. Analysis of Drug Interactions in Pharmacological Treatments πŸ”¬
  4. Exploring Traditional and Modern Herbal Remedies for Therapeutic Use 🌱
  5. Critical Evaluation of Clinical Drug Trials and Their Impact on Healthcare πŸ§ͺ
  6. Advances in Clinical Pharmacy and Patient Care Management πŸ₯
  7. Pharmacological Innovations: A New Era in Medicine πŸ’‘
  8. Evaluation of Herb-Drug Interactions: Clinical Implications πŸ“š

Conclusion:

Ihab Abdulwahid Ibrahim is an outstanding candidate for the Best Researcher Award due to his significant contributions to the field of pharmacology, especially in exploring the effects of medications and herbs. His academic qualifications, hands-on experience, and dedication to research excellence make him a strong contender for this prestigious award. By focusing on broadening his research network and expanding publication efforts, Ihab is well-positioned to continue making meaningful advancements in the field of clinical pharmacy and pharmacology.

 

 

 

Pawanpreet Singh | Pharmacy | Best Researcher Award

Assoc. Prof. Dr. Pawanpreet Singh | Pharmacy | Best Researcher Award

Assoc. Prof. Dr. Pawanpreet Singh , RIMT University , India

Dr. Pawanpreet Singh is an accomplished academic and researcher in the field of Pharmaceutical and Medicinal Chemistry. He currently serves as an Associate Professor at RIMT University, Punjab, with a focus on Crystal Engineering, Polymorphism, Co-crystallization, and Pharmaceutical Solids Modification. With over a decade of experience in teaching and research, he has contributed to various scientific advancements, particularly in pharmaceutical solid dosage forms. Dr. Singh has worked as a Postdoctoral Fellow at Dr. Reddy’s Laboratories and as a UGC-Research Fellow at Panjab University. He has also presented at international conferences and has been a part of significant research projects in pharmaceutical sciences. His expertise in computational modelling, crystallography, and formulation R&D is highly regarded, and he is a dedicated educator and mentor in the field.

Publication Profile:

Scopus

Strengths for the Award:

  1. Extensive Academic Background: Dr. Pawanpreet Singh has an impressive academic record, holding a Ph.D. in Pharmaceutical Chemistry and M.Pharm. with distinction. His research work is extensive and covers key areas in pharmaceutical and medicinal chemistry, including crystal engineering, polymorphism, and co-crystallization.
  2. Diverse Research Experience: Dr. Singh has significant research experience across various esteemed institutions, including RIMT University, Panjab University, and I.K. Gujral Punjab Technical University. His research areas, including pharmaceutical solids modification and clinical research, demonstrate his broad expertise.
  3. Postdoctoral and Industry Experience: His postdoctoral work at Dr. Reddy’s Laboratories, focusing on formulation R&D and quality improvement programs, shows practical industry application and hands-on experience in improving pharmaceutical processes, which further strengthens his credentials.
  4. Innovation and Publications: Dr. Singh has contributed several high-impact research papers in reputable journals, many of which are focused on crystal engineering and pharmaceutical development. His work on polymorph prediction and crystal structure determination has the potential to significantly impact drug design and development.
  5. Awards and Recognition: His consistent achievements, including an international travel award and recognition for his poster presentations at prestigious global conferences, highlight his reputation in the research community.
  6. Patents and Book Publications: Dr. Singh has been granted a patent for “Novel cocrystals of aceclofenac with improved bioavailability,” which showcases his innovation and contribution to pharmaceutical sciences. He has also authored books on medicinal chemistry and drug development.
  7. Hands-On Skills and Workshops: His active participation in various hands-on workshops, such as those on X-ray diffraction, chromatography, and crystallography, reflects his continuous effort to upgrade his technical skills.
  8. Leadership and Contribution to Academic Development: Dr. Singh’s role as a faculty member, his leadership as a class representative, and his involvement in various academic events demonstrate his leadership skills and commitment to educational advancement.

Areas for Improvement:

  1. Broader Interdisciplinary Collaboration: While Dr. Singh’s expertise in pharmaceutical chemistry is remarkable, expanding his research into more interdisciplinary domains, such as nanotechnology, biotechnology, and personalized medicine, could open new frontiers in his research career. Collaborating with experts from other fields could enhance the scope and impact of his work.
  2. Increased Research Visibility: Although Dr. Singh has made substantial contributions through publications and presentations, he could further enhance the visibility of his work by focusing on publishing in higher-impact journals or in interdisciplinary fields, where his work could influence broader scientific communities.
  3. Mentorship and Supervision: Given his considerable academic background, taking a more active role in mentoring Ph.D. and postdoctoral researchers could further contribute to the academic and research community. Increased focus on guiding future researchers would build a legacy of innovation and research excellence.
  4. Expanding International Collaborations: Although Dr. Singh has attended international conferences and presented posters globally, strengthening long-term international research collaborations could lead to more groundbreaking and globally impactful research projects.

Education:

Dr. Pawanpreet Singh completed his PhD in Pharmaceutical Sciences from the University Institute of Pharmaceutical Sciences, Panjab University, in 2018, under the supervision of Prof. Renu Chadha. His doctoral research focused on Crystal Engineering and Protein Binding Studies for antibacterial agents. Prior to this, he earned his Master’s in Pharmacy (M.Pharm) from G.H.G Khalsa College of Pharmacy in 2010, specializing in Pharmaceutical Chemistry with distinction. His undergraduate studies (B.Pharm) were completed at the same institution, where he achieved a first division. Dr. Singh also completed his secondary education at SCD Government College for Boys, Ludhiana, securing top positions. His strong academic foundation is further supported by certifications in specialized areas such as FTIR, HPLC, and X-ray diffraction, contributing to his expertise in medicinal chemistry and pharmaceutical research.

Experience:

Dr. Pawanpreet Singh has a rich academic and industrial experience spanning over a decade. He currently serves as an Associate Professor at RIMT University, Punjab, since February 2023, focusing on Pharmaceutical and Medicinal Chemistry. Prior to this role, he was an Assistant Professor at RIMT University, College of Pharmacy (September 2022 – February 2023) and at I.K. Gujral Punjab Technical University (November 2020 – June 2022). Dr. Singh has significant industrial exposure as a Postdoctoral Fellow at Dr. Reddy’s Laboratories (2017-2020), where he worked on Formulation R&D, technology transfer, and quality improvement. His research contributions are further backed by his work as a UGC-Research Fellow at Panjab University (2012-2017), under the guidance of Prof. Renu Chadha. With expertise in crystallography, formulation science, and computational modelling, he has developed several pharmaceutical products and processes, enhancing his academic and practical approach in research and teaching.

Awards and Honors:

Dr. Pawanpreet Singh has received numerous awards and honors throughout his career. He was awarded the prestigious UGC-Research Fellowship in Science for Meritorious Students (RFSMS) in 2012 for his outstanding academic performance. Dr. Singh also received the International Travel Award from the Department of Biotechnology, Government of India, to attend the ASM Microbe 2016 conference in Boston, USA. He won the First Prize in a poster presentation at the 10th National Conference on Thermodynamics of Pharmaceutical, Chemical, and Biological Systems in 2015. Additionally, he was recognized for his leadership as the Class Representative of PhD scholars at UIPS, Panjab University (2015-16). Dr. Singh’s research excellence is highlighted by his numerous publications in high-impact journals, and his contribution to the scientific community through his innovative work in pharmaceutical research. His achievements further underline his dedication to advancing pharmaceutical sciences and education.

Research Focus:

Dr. Pawanpreet Singh’s research interests are centered around Pharmaceutical and Medicinal Chemistry, with a particular focus on crystal engineering, polymorphism, and co-crystallization. His work aims to improve the physicochemical properties of pharmaceutical solid dosage forms, including their solubility, bioavailability, and stability. Dr. Singh has extensive experience in the preparation, characterization, and biological evaluation of various pharmaceutical solids, including polymorphs, co-crystals, and eutectics. His research integrates experimental and computational techniques, utilizing tools like CASTEP, Crystal Solve, and molecular docking to predict and characterize crystal structures. He has worked extensively on pharmaceutical polymorph screening and the design of solid forms with enhanced performance. Additionally, Dr. Singh is involved in formulating strategies for drug delivery and developing new methodologies for enhancing the stability and effectiveness of pharmaceutical compounds. His contributions to pharmaceutical solids modification have the potential to lead to more effective treatments with improved pharmacological properties.

Publications Top Notes:

  1. Structural and biopharmaceutical evaluation of newly synthesized norfloxacin co-crystals using crystal engineering approach, Journal of Molecular Structure, 2023 πŸ§‘β€πŸ”¬πŸ’Š
  2. Depicting polymorphism in eutectic mixtures, DOI: 10.21203/rs.3.rs-1708945/v1 πŸ”¬πŸ“‘
  3. A new polymorph of ciprofloxacin saccharinate: Structural characterization and pharmaceutical profile, Journal of Pharmaceutical and Biomedical Analysis, 2017 πŸ’ŠπŸ”
  4. Crystal structure prediction in the context of pharmaceutical polymorph screening and putative polymorphs of ciprofloxacin, International Journal of Pharmacy and Pharmaceutical Sciences, 2017 πŸ”¬πŸ’Š
  5. Ciprofloxacin Hippurate Salt: Crystallization Tactics, Structural Aspects, and Biopharmaceutical Performance, Crystal Growth & Design, 2016 πŸ’ŠπŸ§ͺ
  6. Report on the Sixth Blind Test of Organic Crystal-Structure Prediction Methods, Acta Crystallographica Section B, 2016 πŸ§‘β€πŸ”¬πŸ“‘
  7. New conformational polymorph of Hydrochlorothiazide with improved solubility, Pharmaceutical Development and Technology, 2015 πŸ’§πŸ’Š
  8. Molecular Docking: A challenged and effectual approach, The Pharmacos, 2014 πŸ’»πŸ”¬
  9. Synthesis and thin layer chromatography of some new D-homo azasteroidal compounds, International Journal of Current Research and Review, 2011 πŸ”¬πŸ“„

Conclusion:

Dr. Pawanpreet Singh is highly deserving of the Best Researcher Award due to his deep expertise in pharmaceutical sciences, particularly in crystal engineering, polymorphism, and solid dosage form modification. His academic accomplishments, industrial experience, and significant contributions through research papers and patents make him an exemplary candidate. With continued interdisciplinary collaboration and greater international research visibility, Dr. Singh has the potential to further elevate his impact in the field. His track record of innovative research, mentorship, and leadership in academic settings highlights his commitment to advancing pharmaceutical sciences.